Moderator: - Filipa Alves da Costa, Assistant Professor with Tenure, Faculty of Pharmacy, University of Lisbon, Portugal Panellists: - Cheryl Sadowski, Professor, University of Alberta, Canada - Niamh Lennox-Chhugani, Chief Executive and Director of Research, International Foundation for Integrated Care (IFIC), United Kingdom - Joo Rafael Gonalves, Professor and Senior Researcher, ISBE - Institute for Evidence-Based Health
Brush your teeth
Clinical trials have consistently demonstrated that gastrointestinal adverse effects are most common during the first 48 weeks of therapy and typically diminish as physiological adaptation occurs
Ethics declarations Ethical approval and consent to participate Not applicable
Diabetes 50 , 25632571 (2001)